Big Tech’s Big Day… And Second Half Energy Playbook 7/5/24
CNBC's "Fast Money"
00:00
Discussion on Drug-related Eye Conditions, Stock Performance, and Competitive Landscape in Pharmaceutical Industry
The chapter explores worries surrounding eye conditions from specific medications for type 2 diabetes, despite being considered rare and known for over a year. Stock market reactions to Novo and Lilly are discussed, hinting at investor sentiments amidst recent news events regarding Medicare negotiations and FDA approvals in the pharmaceutical sector.
Play episode from 23:44
Transcript
